DUBLIN--(BUSINESS WIRE)--The "Global Ophthalmology Therapeutics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
The author has been monitoring the global ophthalmology therapeutics market and it is poised to grow by USD 10.42 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period. The reports on global ophthalmology therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in prevalence of eye diseases. In addition, development of novel drug delivery systems is anticipated to boost the growth of the global ophthalmology therapeutics market as well.
Companies Mentioned
- AbbVie Inc.
- Aerie Pharmaceuticals Inc.
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Santen Pharmaceutical Co. Ltd.
-
Teva Pharmaceutical Industries Ltd.
Key Topics Covered:
1. EXECUTIVE SUMMARY
2. SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
3. MARKET LANDSCAPE
- Market ecosystem
- Parent market
- Market characteristics
- Value chain analysis
- Market segmentation analysis
4. MARKET SIZING
- Market definition
- Market sizing 2019
- Market size and forecast 2019-2024
- Market outlook
5. FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
6. MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Retinal disorder therapeutics - Market size and forecast 2019-2024
- Glaucoma therapeutics - Market size and forecast 2019-2024
- Dry eye disease therapeutics - Market size and forecast 2019-2024
- Eye infections and inflammation therapeutics -
- Market size and forecast 2019-2024
- Other therapeutics - Market size and forecast 2019-2024
- Market opportunity by product
7. CUSTOMER LANDSCAPE
8. GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity
9. DECISION FRAMEWORK
10. DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
11. MARKET TRENDS
- Development of novel drug delivery systems
- Increase in strategic alliances
- Increasing research on gene therapy products
12. VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
13. VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- AbbVie Inc.
- Aerie Pharmaceuticals Inc.
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Santen Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
14. APPENDIX
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
For more information about this report visit https://www.researchandmarkets.com/r/2v2vru
